MSF Enhances Human Antimicrobial Peptide β-Defensin (HBD2 and HBD3) Expression and Attenuates Inflammation via the NF-κB and p38 Signaling Pathways

Both defensin and inflammation are part of the human innate immune system that responds rapidly to pathogens. The combination of defensins with pro- or anti-inflammatory effects can be a potential research direction for the treatment of infection by pathogens. This study aimed to identify whether MSF (Miracle Synergy material made using Filipendula glaberrima), a probiotic lysate of Filipendula glaberrima extracts fermented with Lactiplantibacillus plantarum K8, activates the expression of human β-defensin (HBD2 and HBD3) to protect the host against pathogens and inhibit inflammation caused by S. aureus, in vitro with Western blot analysis, qRT-PCR and in vivo studies with a mouse model were used to evaluate the effects of MSF. The MSF treatment induced HBD2 and HBD3 expression via the p38 and NF-κB pathways. Furthermore, MSF treatment significantly reduced the expression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-8), also through p38 and NF-κB in S. aureus-induced inflammatory condition. MSF treatment remarkably reduced erythema in mice ears caused by the injection of S. aureus, while K8 lysate treatment did not initiate a strong recovery. Taken together, MSF induced the expression of HBD2 and HDB3 and activated anti-inflammatory activity more than the probiotic lysates of L. plantarum K8. These findings show that MSF is a potential defensin inducer and anti-inflammatory agent.


Introduction
Skin is the largest organ of the body, and acts as the primary barrier against microbial infection [1]. The protection mechanism of the skin includes the physical representation of the epidermis, stratum corneum, antimicrobial peptides (AMPs), and the physiological representation of innate immune responses [1][2][3]. While barrier defenses are the body's first line of physical defense systems, innate immune responses are the first line of physiological defense systems against pathogens [1,3]. Indeed, both mechanisms can cooperate, and one can stimulate the other in their responses against pathogens.
Human defensins work as a part of the innate immune system and are a major family of AMPs expressed predominantly in epithelial cells and neutrophils [4]. Human defensins consist of two genetically distinct forms, α-and β-defensins [5]. Human α-defensins are mainly found in granules of polymorphonuclear leukocytes (HNP1-4) and in small intestinal Paneth cells (HBD5 and HBD6), whereas human β-defensins (HBD1-4) are found in leukocytes and epithelial cells [5,6]. HBD1 is constitutively activated, while HBD2 and HBD3 are inducible in the presence of a variety of stimuli including infections [5].

MSF Significantly Enhanced the Expression of Human β-Defensin-2 and β-Defensin-3
To test whether MSF induces the expression of genes encoding AMPs (HBD1-3), MSF in concentrations of 25-100 µg/mL was used to treat human keratinocyte cells (HaCaT) for periods of 1-48 h. K8 lysate was used as a control.
Analysis with qRT-PCR showed that MSF significantly induced the expression of HBD2 and HBD3 in a time-and dose-dependent manner ( Figure 1A,B), but the expression of HBD1 was time-dependently decreased ( Figure 1A) and dose-dependently increased ( Figure 1B). MSF treatment increased HBD2 and HBD3 expressions, more than K8 lysate treatment at the same concentration.
The expression of HBD2 and HBD3 protein levels was also induced by treatment with the indicated concentration of MSF ( Figure 1C). MSF should be able to increase the antimicrobial activity of cells against pathogenic bacteria. The expression of HBD2 and HBD3 protein levels was also induced by treatment with the indicated concentration of MSF ( Figure 1C). MSF should be able to increase the antimicrobial activity of cells against pathogenic bacteria.

Effect of MSF on the PI3K, NF-κB, and MAPKs Signaling Pathways in HaCaT Cells
PI3K, NF-κB, and MAPKs signaling pathways have a critical role in innate and adaptive immunity. Class I PI3Ks activate and elicit cellular responses of each cell that expresses receptors for immune responses [12]. The NF-κB and MAPK pathways are key for epithelial immune defense and have been implicated in the secretion of antimicrobial peptides, the release of cytokines/chemokines to mobilize immune effector cells, and the activation of adaptive immunity [13]. Therefore, to determine which pathway among the PI3K, NF-κB, and MAPKs signaling pathways are involved in the regulation of the expression of HBD1, HBD2, and HBD3, HaCaT cells were treated with 25-100 µg/mL of MSF.
The phosphorylation of NF-κB, p38, and ERK1/2 was time-and dose-dependently induced by treatment with MSF or K8 lysate (Figure 2A,B). However, ERK1/2 phosphorylation increased with a dose of 100 µg/mL within 1 h of treatment and decreased after that. qRT-PCR analysis of HBD1, HBD2, and HBD3 mRNA levels in HaCaT after treatment with MSF or K8 lysate. (C) The protein expression of HBD2 and HBD3 was increased by MSF treatment in HaCaT cells for 1 h and Western blot quantification was checked by ImageJ. Values are mean ± SD from three independent experiments. * p < 0.05, ** p < 0.01.

Effect of MSF on the PI3K, NF-κB, and MAPKs Signaling Pathways in HaCaT Cells
PI3K, NF-κB, and MAPKs signaling pathways have a critical role in innate and adaptive immunity. Class I PI3Ks activate and elicit cellular responses of each cell that expresses receptors for immune responses [12]. The NF-κB and MAPK pathways are key for epithelial immune defense and have been implicated in the secretion of antimicrobial peptides, the release of cytokines/chemokines to mobilize immune effector cells, and the activation of adaptive immunity [13]. Therefore, to determine which pathway among the PI3K, NF-κB, and MAPKs signaling pathways are involved in the regulation of the expression of HBD1, HBD2, and HBD3, HaCaT cells were treated with 25-100 µg/mL of MSF.
The phosphorylation of NF-κB, p38, and ERK1/2 was time-and dose-dependently induced by treatment with MSF or K8 lysate (Figure 2A,B). However, ERK1/2 phosphorylation increased with a dose of 100 µg/mL within 1 h of treatment and decreased after that.  In addition, the expression of genes encoding pro-inflammatory mediators such as TNF-α, IL-1β, IL-6, and IL-8, which are generally considered to respond together with antimicrobial peptide genes during the innate immune response, were also investigated. The expression of TNF-α, IL-1β, IL-6, and IL-8 increased slightly in a dose-dependent manner by treatment with MSF or K8 lysate ( Figure S1D, Supplementary Materials). However, the expression of IL-1β, IL-6, and IL-8 was time-dependently reduced by treatment with MSF or K8 lysate, but the expression of TNF-α was induced by the MSF or K8 lysate treatment ( Figure S1C).
Assay with MTT consistently showed that the viability of HaCaT cells was not affected by MSF or K8 lysate treatment up to a concentration of 100 µg/mL ( Figure 2C).
Collectively, treatment with MSF induced the expression of β-defensin (HBD2 and HBD3) and affected the expression of pro-inflammatory genes (TNF-α, IL-1β, IL-6, and IL-8), but it was not clear which pathways, including the p38 and the NF-κB pathways were involved in increasing the expression.

MSF Promoted the Expression of HBD2 and HBD3 through p38 Pathway
To verify whether p38 mediated the HBD2 and HBD3 expression caused by the MSF treatment, SB203580, a specific inhibitor of p38, was used. In the presence of SB203580, the expression of HBD2 and HBD3 did not increase by treatment with 25, 50, and 100 µg/mL of MSF or K8 lysate ( Figure 3A,B). However, a slightly reduced expression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-8) was shown by treatment with MSF or K8 lysate ( Figure S2 compared to Figure S1D). These results suggested that MSF induced the expression of HBD2 and HBD3 through the p38 pathway.  In addition, the expression of genes encoding pro-inflammatory mediators such as TNF-α, IL-1β, IL-6, and IL-8, which are generally considered to respond together with antimicrobial peptide genes during the innate immune response, were also investigated. The expression of TNF-α, IL-1β, IL-6, and IL-8 increased slightly in a dose-dependent manner by treatment with MSF or K8 lysate ( Figure S1D, Supplementary Materials). However, the expression of IL-1β, IL-6, and IL-8 was time-dependently reduced by treatment with MSF or K8 lysate, but the expression of TNF-α was induced by the MSF or K8 lysate treatment ( Figure S1C).
Assay with MTT consistently showed that the viability of HaCaT cells was not affected by MSF or K8 lysate treatment up to a concentration of 100 µg/mL ( Figure 2C).
Collectively, treatment with MSF induced the expression of β-defensin (HBD2 and HBD3) and affected the expression of pro-inflammatory genes (TNF-α, IL-1β, IL-6, and IL-8), but it was not clear which pathways, including the p38 and the NF-κB pathways were involved in increasing the expression.

MSF Promoted the Expression of HBD2 and HBD3 through p38 Pathway
To verify whether p38 mediated the HBD2 and HBD3 expression caused by the MSF treatment, SB203580, a specific inhibitor of p38, was used. In the presence of SB203580, the expression of HBD2 and HBD3 did not increase by treatment with 25, 50, and 100 µg/mL of MSF or K8 lysate ( Figure 3A,B). However, a slightly reduced expression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-8) was shown by treatment with MSF or K8 lysate ( Figure S2 compared to Figure S1D). These results suggested that MSF induced the expression of HBD2 and HBD3 through the p38 pathway.
To verify whether p38 mediated the HBD2 and HBD3 expression caused by the MSF treatment, SB203580, a specific inhibitor of p38, was used. In the presence of SB203580, the expression of HBD2 and HBD3 did not increase by treatment with 25, 50, and 100 µg/mL of MSF or K8 lysate ( Figure 3A,B). However, a slightly reduced expression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-8) was shown by treatment with MSF or K8 lysate ( Figure S2 compared to Figure S1D). These results suggested that MSF induced the expression of HBD2 and HBD3 through the p38 pathway.  Values are mean ± SD from three independent experiments. * p < 0.05, ** p < 0.01.

NF-κB Involved in the Induction of HBD3 and HBD2 Expression
To examine whether MSF treatment increases HBD2 and HBD3 expression through the NF-κB pathway, HaCaT cells were pre-treated for 3 h with SP100030, an NF-κB specific inhibitor, and then treated with 25-100 µg/mL of MSF or K8 lysate for 1 h. The phosphorylated form of NF-κB was not induced by treatment with MSF or K8 lysate after the treatment with SP100030 ( Figure 4A compared to Figure 2B). Inhibition of NF-κB de-

NF-κB Involved in the Induction of HBD3 and HBD2 Expression
To examine whether MSF treatment increases HBD2 and HBD3 expression through the NF-κB pathway, HaCaT cells were pre-treated for 3 h with SP100030, an NF-κB specific inhibitor, and then treated with 25-100 µg/mL of MSF or K8 lysate for 1 h. The phosphorylated form of NF-κB was not induced by treatment with MSF or K8 lysate after the treatment with SP100030 ( Figure 4A compared to Figure 2B). Inhibition of NF-κB decreased the expression of HBD2 and HBD3 by treatment with MSF and K8 lysate ( Figure 4B). Furthermore, the expression of pro-inflammatory genes (TNF-α, IL-1β, IL-6, and IL-8) decreased slightly depending on the concentration of the MSF treatment ( Figure S3 compared to Figure S1D). Overall, MSF treatment increased the expression of HBD2 and HBD3 via the NF-κB pathway.
Molecules 2023, 28, x FOR PEER REVIEW 9 of 21 compared to Figure S1D). Overall, MSF treatment increased the expression of HBD2 and HBD3 via the NF-κB pathway.

MSF Inhibited S. aureus-Induced Inflammation in THP1 Cells
Staphylococcus aureus (S. aureus) infections play an extremely important role in a variety of diseases including inflammation diseases. S. aureus triggers major intracellular signaling pathways: MAPK pathways including p38, ERK1/2, and JNK, and the pathway leading to activation of the transcription factor NF-κB. To test the anti-inflammatory ef-

MSF Inhibited S. aureus-Induced Inflammation in THP1 Cells
Staphylococcus aureus (S. aureus) infections play an extremely important role in a variety of diseases including inflammation diseases. S. aureus triggers major intracellular signaling pathways: MAPK pathways including p38, ERK1/2, and JNK, and the pathway leading to activation of the transcription factor NF-κB. To test the anti-inflammatory effects of MSF and K8 lysate in THP1 cells, THP1 cells were pre-treated with 25-100 µg/mL of MSF or K8 lysate for 1 h, and then cultured with heat-killed S. aureus for 24 h. The treatment of heatkilled S. aureus increased the expression of pro-inflammatory cytokines including TNF-α, IL-1β, IL-6, and IL-8, while treatment with MSF or K8 lysate significantly inhibited the gene expression of the pro-inflammatory cytokines to a similar extent in a dose-dependent manner ( Figures S4 and 5A).
Molecules 2023, 28, x FOR PEER REVIEW 10 of 21 of MSF or K8 lysate for 1 h, and then cultured with heat-killed S. aureus for 24 h. The treatment of heat-killed S. aureus increased the expression of pro-inflammatory cytokines including TNF-α, IL-1β, IL-6, and IL-8, while treatment with MSF or K8 lysate significantly inhibited the gene expression of the pro-inflammatory cytokines to a similar extent in a dose-dependent manner ( Figure S4 and Figure 5A).
(A) The MAPKs, including p38, ERK1/2, and JNK, are involved in the signal transduction pathways and NF-κB is critically required for the transcriptional regulation of genes for inflammation [14][15][16][17]. Accordingly, the inflammatory response after MSF treatment through the MAPKs or NF-κB pathway in S. aureus-treated THP1 cells was tested by Western blot analysis. The treatment of S. aureus induced the phosphorylation of NF-κB and p38, but not ERK1/2 and JNK. MSF reduced NF-κB and p38 phosphorylation which was increased by the treatment with S. aureus ( Figure 5B).
In addition, MSF and K8 lysate did not show any toxicity to the THP1 cells ( Figure 5C). Therefore, MSF showed anti-inflammatory effects by suppressing the expression of proinflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-8) through the NF-κB and p38 pathways.

TLR2 Was Involved in Regulating Human β-Defensin and Inflammation of MSF
TLR2 and TLR4 play crucial roles in modulating inflammatory response by recognizing different bacterial cell wall components, then activating the transcription factors via intracellular pathways, and generating cytokines and chemokines [18,19].
The expression of TLR2 and TLR4 were tested after treatment with 25-100 µg/mL MSF or K8 lysate to determine to check whether compounds influence the ability of TLR2 and TLR4 to regulate the expression of HBD2, HBD3, and pro-inflammation cytokines. TLR2 expression was increased by treatments with either MSF or K8 lysate, while TLR4 expression decreased ( Figure 6A). In addition, the mRNA gene expression of TLR2 and TLR4 was reduced by MSF or K8 lysate treatment in S. aureus-stimulated THP1 cells ( Figure 6B) and similar results with protein levels ( Figure 6C). These results suggested that TLR2 plays a role in regulating the expression of defensin and inflammatory cytokines by MSF treatment. The MAPKs, including p38, ERK1/2, and JNK, are involved in the signal transduction pathways and NF-κB is critically required for the transcriptional regulation of genes for inflammation [14][15][16][17]. Accordingly, the inflammatory response after MSF treatment through the MAPKs or NF-κB pathway in S. aureus-treated THP1 cells was tested by Western blot analysis. The treatment of S. aureus induced the phosphorylation of NF-κB and p38, but not ERK1/2 and JNK. MSF reduced NF-κB and p38 phosphorylation which was increased by the treatment with S. aureus ( Figure 5B).
In addition, MSF and K8 lysate did not show any toxicity to the THP1 cells ( Figure 5C). Therefore, MSF showed anti-inflammatory effects by suppressing the expression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-8) through the NF-κB and p38 pathways.

TLR2 Was Involved in Regulating Human β-Defensin and Inflammation of MSF
TLR2 and TLR4 play crucial roles in modulating inflammatory response by recognizing different bacterial cell wall components, then activating the transcription factors via intracellular pathways, and generating cytokines and chemokines [18,19].
The expression of TLR2 and TLR4 were tested after treatment with 25-100 µg/mL MSF or K8 lysate to determine to check whether compounds influence the ability of TLR2 and TLR4 to regulate the expression of HBD2, HBD3, and pro-inflammation cytokines. TLR2 expression was increased by treatments with either MSF or K8 lysate, while TLR4 expression decreased ( Figure 6A). In addition, the mRNA gene expression of TLR2 and TLR4 was reduced by MSF or K8 lysate treatment in S. aureus-stimulated THP1 cells ( Figure 6B) and similar results with protein levels ( Figure 6C). These results suggested that TLR2 plays a role in regulating the expression of defensin and inflammatory cytokines by MSF treatment.

MSF Ameliorated S. Aureus-Induced Skin Inflammation in Mice
The in vivo pathophysiological effect of MSF using a BALB/cAnNTac mouse model was evaluated ( Figure 7A). To achieve S. aureus-induced inflammation in the mouse model, 10 8 colony-forming units (CFUs) of living S. aureus were intradermally injected

MSF Ameliorated S. Aureus-Induced Skin Inflammation in Mice
The in vivo pathophysiological effect of MSF using a BALB/cAnNTac mouse model was evaluated ( Figure 7A). To achieve S. aureus-induced inflammation in the mouse model, 10 8 colony-forming units (CFUs) of living S. aureus were intradermally injected into the ears of the mouse. After 24 h of S. aureus administration, the ears exhibited significant cutaneous erythema and swelling, a typical symptom of ear inflammation ( Figure 7B, right ear). MSF treatment remarkably reduced erythema comparable to no treatment (S. aureus injection only), while K8 lysate treatment did not show a strong recovery ( Figure 7B, left ear).  To verify the reduction in ear inflammation by MSF treatment, the expression of proinflammatory cytokines such as TNF-α, IL-1β, IL-6, and IL-8 was tested using qRT-PCR. S. aureus injection increased the expression of TNF-α, but treatment with MSF significantly decreased the expression of TNF-α ( Figure 7C). The expression of IL-1β and IL-6 was not decreased when treated with MSF in the S. aureus-stimulated left mouse ear ( Figure 7C). IL-8 was undetectable. Together, the data demonstrate that MSF reduced the inflammatory response caused by S. aureus injection in mice ears.

Discussion
Defensins are effector molecules of the innate host defense system with antimicrobial activity against a variety of pathogens, including S.aureus [5]. Human β-defensin is an important factor to induce or regulate the host defense and may bridge innate and adaptive immunity at surfaces [5].
F. glaberrima Nakai has been used as a remedy to treat inflammation, pain, and gout and the ethanol extract of F. glaberrima Nakai on anti-inflammatory activity has been reported [11]. In addition, L. plantarum K8 lysate has shown anti-inflammatory effects and alleviated lipopolysaccharide (LPS)-induced septic shock [9].
Due to this, we hypothesized that MSF, a fermented product of F. glaberrima Nakai with L. plantarum K8, was a potential candidate to be a defensin inducer and an anti-inflammatory agent. To explore these possibilities, the expressions of β-defensin HBD1, HBD2, and HBD3 were tested after treatment with MSF. MSF treatment induced the expression of the mRNA and protein levels of HBD2 and HBD3 (Figure 1). Three important pathways (PI3K, NF-κB, and MAPKs) in the inflammatory response were concurrently checked to determine which participated in the regulation of the expression of defensin and inflammatory cytokines after treatment with MSF. MSF treatment activated HBD2 and HBD3 expression through the NF-κB and p38 pathways (Figures 1 and 2). Early responses indicated that NF-κB and p38 were activated after only 1 h treatment, but not PI3K, AKT, and JNK signaling when HaCaT cells were treated with MSF or K8 lysate. ERK1/2 was also activated but only for the first 1 h and decreased thereafter, so we did not check ERK1/2 in this study.
The MAPK signaling pathway has important roles in innate immune responses, ranging from the induction of pro-inflammatory mediators, such as cytokines and chemokines, to the activation of anti-inflammatory feedback pathways [14,15]. In mammalian cells, there are three well-defined MAPK pathways: the extracellular-signal-regulated kinase (ERK) pathway, the JUN N-terminal kinase (JNK) pathway, and the p38 pathway [14,15]. p38 is protective in multiple autoimmune and inflammatory. The mRNA and protein expression of HBD2 and HBD3 by MSF or K8 lysate treatment were mediated through p38 signaling (Figures 1 and 2). Inhibition of the p38 pathway by SB203580 blocked the induction of HBD2 and HBD3, confirming the central role of p38 in the regulation of HBD2 and HBD3 expression (Figure 3).
The transcription factor NF-κB regulates the expression of a large array of genes involved in processes of the immune and adaptive immune functions and serves as a pivotal mediator of inflammatory responses [16,17]. NF-κB has long been considered a prototypical pro-inflammatory signaling pathway, largely based on the induction of the expression of several pro-inflammatory genes, including those genes encoding cytokines, chemokines, and inflammasome regulation [16,17]. Treatment of MSF or K8 lysate with NF-κB inhibitor showed that NF-κB enhanced HBD2, HBD3, confirming NF-κB regulated HBD2 and HBD3 expression (compare Figure 1, Figure 2, and Figure 4).
Taken together, MSF activated both NF-κB and p38 pathways, all p38 and NF-κB induced the expression of the HBD2 and HBD3. All these results showed that MSF possessed antimicrobial activity and could provide the first line of defense in the immune system.
On another hand, treatment with MSF influenced the expression of TNF-α, IL-1β, IL-6, and IL-8 via p38 and NF-κB signaling pathways (Figures S1-S3). The differential transcriptional activation of pro-inflammatory genes is precisely controlled by the selective binding of transcription factors to the promoter of these genes. Furthermore, many signaling pathways regulate the expression of pro-inflammatory cytokine genes. NF-κB, p38, and ERK1/2 are upstream signaling of TNF-α, IL-1β, IL-6, and IL-8. Therefore, the different expressions of NF-κB, p38, and ERK1/2 lead to the different expression patterns of TNF-α, IL-1β, IL-6, and IL-8.
In addition, S. aureus induced pro-inflammatory gene expression in THP1 cells, while MSF reduced inflammatory responses caused by S. aureus (Figures S4 and 5). Inhibition of the signaling cascade including p38 or NF-κB by MSF could lead to suppression of inflammatory gene expression in S. aureus-stimulated THP1 cells with higher anti-inflammatory efficacy than conventional probiotic lysates (K8 lysate). However, compared with the previously reported anti-inflammatory response of MSF [9], the different experimental conditions led to a slightly different pattern of gene expression. Therefore, we can suggest that MSF has a potential anti-inflammatory activity.
The toll-like receptor is a pattern recognition receptor that has a key role in enabling cells of the innate immune system to recognize the conserved structural motifs on a wide array of pathogens including Gram-positive bacteria [18,19]. The treatment of MSF increased the expression of TLR2, but not TRL4 ( Figure 6) suggesting that MSF activated TLR2 leading to the expression of pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6, and IL-8 through the p38 or NF-κB pathways.
To determine the physiological effect of MSF on the S. aureus infection condition, we used a well-known mouse model. Injection of S. aureus increased the relative ratio of ear swelling, but treatment with 100 µg/mL MSF significantly decreased ear swelling ( Figure 7B). Furthermore, the expression of TNF-α was reduced ( Figure 7C), but IL-6 and IL-1β in the ears of mice treated with MSF are higher than that in the other ear. In this experiment, while the mice's ears were sampled for RT-PCR, the tissues included various cell types in the skin that produced cytokines. It is possible that the reductions or inductions in cytokine expression could occur in these cell types as well. Additionally, the IL-6 and IL-1β gene expression might be less sensitive to MSF inhibition S. aureus-induced inflammation compared to TNF-α in vivo model. Alternatively, it could be that IL-6 and IL-1β downregulation by MSF in our mice is regulated by other pathways. These results suggested that MSF ameliorated S. aureus-induced inflammation by reducing the expression of cytokines.
Based on these results, we proposed a possible mechanism for how MSF induces the expression of human β-defensins and inhibits the inflammation caused by S. aureus ( Figure 8).

Preparation of MSF
MSF was prepared based on a previous report by culturing L. plantarum K8 in De Man, Rogosa, and Sharpe (MRS) broth (BD Bioscience, San Jose, CA, USA), containing F. glaberrima Nakai extracts [9]. Cultivation was carried out by inoculating the prepared extract of F. glaberrima Nakai into the inoculum of L. plantarum K8 at 37 °C overnight and recovering the lactic acid bacteria cells using a continuous centrifugal separator. Bacteria were re-suspended in deionized water and disrupted by a microfluidizer (MN400BF, Mi- Figure 8. Schematic diagram illustrating the proposed mechanism by which MSF induces the expression of HBD2, and HBD3 and suppresses S. aureus-induced inflammatory responses by activating TLR2 through the p38 and NF-κB signaling pathways.

Western Blot Analysis
Cells were washed with phosphate-buffered saline (PBS) and lysed in radioimmunoprecipitation assay (RIPA) lysis buffer containing 150 mM sodium chloride, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 50 mM Tris (pH 8.0), and complete protease inhibitor cocktail (BIOMAX, Gyeonggi, Republic of Korea). Protein concentration was determined by a Brandford (Sigma-Aldrich, St. Louis, MO, USA) assay with bovine serum albumin (BSA) as a standard and detected using a UVITEC imaging system (Uvitec Ltd., Cambridge, UK). Denatured proteins (50 µg) were separated with SDS-PAGE and transferred onto PVDF membranes by a wet transfer apparatus (Bio-Rad, Hercules, CA, USA). Membranes were blocked with 5% BSA (Bioshop, Ontario, Canada) or 5% non-fat milk (Bio-Rad, Hercules, CA, USA) for 1-2 h at room temperature, and then probed with primary antibodies overnight and secondary HRP-conjugated IgG antibody for 1 h at room temperature ( Table 2). The protein expression was determined with an ECL reagent (Bio-Rad, Hercules, CA, USA) and detected with a UVITEC imaging system. The results presented are representative of at least three independent experiments.

Animal Experiments
Female BALB/cAnNTac mice (6-8 weeks old) were purchased from JA BIO (Suwon, Republic of Korea). Mice were maintained under standard laboratory conditions (24 ± 2 • C and 50 ± 10% relative humidity). Mice were allowed to acclimate for 1 week before the experiment began. Mice were randomly divided into six groups (Table 3) and three independent experiments were performed [22,23]. At the end of the experiment, mice were sacrificed whose ears were sampled for qRT-PCR.

Statistical Analysis
Data are expressed as the mean ± standard deviations (SD) of three independent experiments. Statistical analysis was performed with GraphPad Prism 5 (GraphPad software). One-way ANOVA with Tukey's multiple comparisons was used when there were more than two groups. Student's test was used for normally distributed data analysis. p-values of less than 0.05, 0.01, or 0.001 were considered statistically significant.

Conclusions
Defensins have versatile immune functions that are pivotal for both inhibiting the growth of pathogens and disease progression. This study aimed to provide a platform for designing defensin-based strategies against human microbial pathogens by fermentation products such as MSF. Furthermore, MSF showed strong anti-inflammatory activity that can be used for cosmetic purposes or to develop the lead source of a compound for a new anti-inflammatory medicine.